BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-103.04M
↑ 21% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-131.21M
Historical baseline
PeriodValueYoY Change
TTM$-103.04M-5.8%
2024$-97.42M-0.8%
2023$-96.69M+20.1%
2022$-120.96M-1.5%
2021$-119.22M+13.3%
2020$-137.52M+5.2%
2019$-145.03M-0.3%
2018$-144.62M+27.4%
2017$-199.22M-34.3%
2016$-148.38M-